AXSM Axsome Therapeutics
- 74.820
- +1.130+1.53%
Axsome Therapeutics News
Axsome Therapeutics | DEF 14A: Definitive information statements
Axsome Therapeutics | ARS: Annual Report to Security Holders
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.
Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 8-K: Current report
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Axsome Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzie Nick
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer TABUTEAU HERRIOT
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murdock Hunter R.
Axsome Therapeutics | 10-K: Annual report
Axsome Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
